Showcases TriCell, NOVASTEM BC, BMAC, and Other Medical Devices
REV-MED participated in the "Medical Fair Asia Singapore 2024," Southeast Asia’s largest bio-healthcare exhibition, held from September 11 to 13 at Marina Bay Sands, Singapore.
The exhibition featured a wide range of bio-healthcare sectors, including hospital equipment, diagnostic technologies, and rehabilitation devices. More than 45 countries showcased their latest medical technologies and products.
REV-MED presented its flagship medical devices, including the TriCell, which extracts stem cells and biological agents from blood and bone marrow, as well as the NOVASTEM BC (Blood Cell) and BMAC (Bone Marrow Aspirate Concentrate).
Additionally, the company exhibited its Hithera 4.0, a medical laser device that safely delivers laser energy deep into tissues without causing thermal damage, and the ReWave, a solid-state microwave wavelength-based beauty device.
Particular attention was drawn to the TriCell and NOVASTEM, which are used to treat autoimmune diseases such as chronic refractory urticaria, infertility, and refractory dry eye syndrome.
These two products employ a three-chamber system with a dual centrifugation process, enabling the efficient concentration of stem cells and immune cells from blood and bone marrow. Their short operation times and user-friendly extraction and infusion designs were highly praised.
A REV-MED representative stated, “All devices must continuously reinforce their scientific evidence to lead the global market. As the only domestic company with both PMDA (Japan) and NMPA (China) certifications, we are committed to realizing our corporate vision of ‘extending human life and overcoming disease.’”
Source: DailyMedi
https://www.dailymedi.com/news/news_view.php?wr_id=916651
Showcases TriCell, NOVASTEM BC, BMAC, and Other Medical Devices
REV-MED participated in the "Medical Fair Asia Singapore 2024," Southeast Asia’s largest bio-healthcare exhibition, held from September 11 to 13 at Marina Bay Sands, Singapore.
The exhibition featured a wide range of bio-healthcare sectors, including hospital equipment, diagnostic technologies, and rehabilitation devices. More than 45 countries showcased their latest medical technologies and products.
REV-MED presented its flagship medical devices, including the TriCell, which extracts stem cells and biological agents from blood and bone marrow, as well as the NOVASTEM BC (Blood Cell) and BMAC (Bone Marrow Aspirate Concentrate).
Additionally, the company exhibited its Hithera 4.0, a medical laser device that safely delivers laser energy deep into tissues without causing thermal damage, and the ReWave, a solid-state microwave wavelength-based beauty device.
Particular attention was drawn to the TriCell and NOVASTEM, which are used to treat autoimmune diseases such as chronic refractory urticaria, infertility, and refractory dry eye syndrome.
These two products employ a three-chamber system with a dual centrifugation process, enabling the efficient concentration of stem cells and immune cells from blood and bone marrow. Their short operation times and user-friendly extraction and infusion designs were highly praised.
A REV-MED representative stated, “All devices must continuously reinforce their scientific evidence to lead the global market. As the only domestic company with both PMDA (Japan) and NMPA (China) certifications, we are committed to realizing our corporate vision of ‘extending human life and overcoming disease.’”
Source: DailyMedi
https://www.dailymedi.com/news/news_view.php?wr_id=916651